Evidence map›Paper›PMID 35338239›Full record

ArticleScientific reports2022

Restoration of antibacterial activity of inactive antibiotics via combined treatment with a cyanographene/Ag nanohybrid.

Lucie Hochvaldová, David Panáček, Lucie Válková, Robert Prucek, Věra Kohlová, Renata Večeřová, Milan Kolář, Libor Kvítek, Aleš Panáček

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lucie HochvaldováDepartment of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
David PanáčekDepartment of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
Lucie VálkováDepartment of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
Robert PrucekDepartment of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
Věra KohlováDepartment of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
Renata VečeřováDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Hněvotínská 5, 775 15, Olomouc, Czech Republic.
Milan KolářDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Hněvotínská 5, 775 15, Olomouc, Czech Republic.
Libor KvítekDepartment of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic.
Aleš PanáčekDepartment of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic. ales.panacek@upol.cz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of antibiotic-resistant bacterial strains is increasing due to the excessive and inappropriate use of antibiotics, which are therefore becoming ineffective. Here, we report an effective way of enhancing and restoring the antibacterial activity of inactive antibiotics by applying them together with a cyanographene/Ag nanohybrid, a nanomaterial that is applied for the first time for restoring the antibacterial activity of antibiotics. The cyanographene/Ag nanohybrid was synthesized by chemical reduction of a precursor material in which silver cations are coordinated on a cyanographene sheet. The antibacterial efficiency of the combined treatment was evaluated by determining fractional inhibitory concentrations (FIC) for antibiotics with different modes of action (gentamicin, ceftazidime, ciprofloxacin, and colistin) against the strains Escherichia coli, Pseudomonas aeruginosa, and Enterobacter kobei with different resistance mechanisms. Synergistic and partial synergistic effects against multiresistant strains were demonstrated for all of these antibiotics except ciprofloxacin, which exhibited an additive effect. The lowest average FICs equal to 0.29 and 0.39 were obtained for colistin against E. kobei and for gentamicin against E. coli, respectively. More importantly, we have experimentally confirmed for the first time, that interaction between the antibiotic's mode of action and the mechanism of bacterial resistance strongly influenced the combined treatment's efficacy.

Indexed as

Anti-Bacterial AgentsColistinCiprofloxacinDrug SynergismEscherichia coliGentamicinsMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial AgentsCiprofloxacinColistinGentamicins

Identifiers

PMID35338239
PMCPMC8956642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.